These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 16537392

  • 1. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Woo JT, Kawatani M, Kato M, Shinki T, Yonezawa T, Kanoh N, Nakagawa H, Takami M, Lee KH, Stern PH, Nagai K, Osada H.
    Proc Natl Acad Sci U S A; 2006 Mar 21; 103(12):4729-34. PubMed ID: 16537392
    [Abstract] [Full Text] [Related]

  • 2. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
    Muguruma H, Yano S, Kakiuchi S, Uehara H, Kawatani M, Osada H, Sone S.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8822-8. PubMed ID: 16361571
    [Abstract] [Full Text] [Related]

  • 3. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss.
    Li JX, Liu J, He CC, Yu ZY, Du Y, Kadota S, Seto H.
    Maturitas; 2007 Sep 20; 58(1):59-69. PubMed ID: 17658706
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
    Zhao Y, Huai Y, Jin J, Geng M, Li JX.
    Menopause; 2011 Jun 20; 18(6):690-7. PubMed ID: 21228726
    [Abstract] [Full Text] [Related]

  • 6. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T, Williams P, Rhine C, Boyce BF, Dunstan C, Mundy GR.
    Cancer Res; 1995 May 01; 55(9):1989-93. PubMed ID: 7728770
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats.
    Mendoza S, Noa M, Mas R, Mendoza N.
    Drugs Exp Clin Res; 2005 May 01; 31(5-6):181-91. PubMed ID: 16425974
    [Abstract] [Full Text] [Related]

  • 8. Reveromycin A-Induced Apoptosis in Osteoclasts Is Not Accompanied by Necrosis.
    Mead B, Morgan H, Mann-Knowlton A, Tedeschi L, Sloan C, Lang S, Hines C, Gragg M, Stofer J, Riemann K, Derr T, Heller E, Collins D, Landis P, Linna N, Jones D.
    J Cell Biochem; 2015 Aug 01; 116(8):1646-57. PubMed ID: 25754900
    [Abstract] [Full Text] [Related]

  • 9. Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood.
    Penolazzi L, Pocaterra B, Tavanti E, Lambertini E, Vesce F, Gambari R, Piva R.
    Apoptosis; 2008 Apr 01; 13(4):553-61. PubMed ID: 18307044
    [Abstract] [Full Text] [Related]

  • 10. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A, Rogers MJ, Idris AI, Crockett JC.
    Calcif Tissue Int; 2007 Nov 01; 81(5):403-13. PubMed ID: 17982704
    [Abstract] [Full Text] [Related]

  • 11. Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures.
    Nicolin V, Bareggi R, Baldini G, Bortul R, Martinelli B, Narducci P.
    Acta Histochem; 2007 Nov 01; 109(5):397-402. PubMed ID: 17574655
    [Abstract] [Full Text] [Related]

  • 12. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
    Koh JM, Lee YS, Kim YS, Park SH, Lee SH, Kim HH, Lee MS, Lee KU, Kim GS.
    Bone; 2009 Oct 01; 45(4):650-60. PubMed ID: 19527807
    [Abstract] [Full Text] [Related]

  • 13. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
    Heath DJ, Vanderkerken K, Cheng X, Gallagher O, Prideaux M, Murali R, Croucher PI.
    Cancer Res; 2007 Jan 01; 67(1):202-8. PubMed ID: 17210700
    [Abstract] [Full Text] [Related]

  • 14. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
    Kameda T, Miyazawa K, Mori Y, Yuasa T, Shiokawa M, Nakamaru Y, Mano H, Hakeda Y, Kameda A, Kumegawa M.
    Biochem Biophys Res Commun; 1996 Mar 27; 220(3):515-9. PubMed ID: 8607797
    [Abstract] [Full Text] [Related]

  • 15. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y.
    Bone; 2007 Aug 27; 41(2):165-74. PubMed ID: 17560185
    [Abstract] [Full Text] [Related]

  • 16. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
    Marie PJ.
    Curr Opin Rheumatol; 2006 Jun 27; 18 Suppl 1():S11-5. PubMed ID: 16735840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo studies of the effect of a Chinese herb medicine on osteoclastic bone resorption.
    Yu S, Chen K, Li S, Zhang K.
    Chin J Dent Res; 1999 Feb 27; 2(1):7-11. PubMed ID: 10557176
    [Abstract] [Full Text] [Related]

  • 20. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E, Chabadel A, Saltel F, Jurdic P.
    Bone; 2008 Jan 27; 42(1):129-38. PubMed ID: 17945546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.